Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 3
1998 1
2000 2
2002 1
2003 3
2004 6
2005 11
2006 12
2007 17
2008 50
2009 61
2010 69
2011 72
2012 74
2013 74
2014 61
2015 51
2016 54
2017 35
2018 42
2019 50
2020 59
2021 42
2022 39
2023 38
2024 25
2025 16

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

853 results

Results by year

Filters applied: . Clear all
Page 1
Doripenem.
[No authors listed] [No authors listed] 2024 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 29999668 Free Books & Documents. Review.
Doripenem is no longer marketed in the US. No information is available on the clinical use of doripenem during breastfeeding. ...Occasionally disruption of the infant's gastrointestinal flora, resulting in diarrhea or thrush has been reported with beta-lactams, but …
Doripenem is no longer marketed in the US. No information is available on the clinical use of doripenem during breastfeeding. …
Doripenem.
Paterson DL, Depestel DD. Paterson DL, et al. Clin Infect Dis. 2009 Jul 15;49(2):291-8. doi: 10.1086/600036. Clin Infect Dis. 2009. PMID: 19527173 Review.
In vitro, resistant P. aeruginosa mutants appear to be harder to select with doripenem than with other carbapenems. Doripenem has been approved for use in treatment of complicated intra-abdominal infection and complicated urinary tract infection. ...The longevity of …
In vitro, resistant P. aeruginosa mutants appear to be harder to select with doripenem than with other carbapenems. Doripenem …
Doripenem.
Anderson DL. Anderson DL. Drugs Today (Barc). 2006 Jun;42(6):399-404. doi: 10.1358/dot.2006.42.6.985634. Drugs Today (Barc). 2006. PMID: 16845443 Review.
Doripenem is a new member of the carbapenem class of beta-lactam antibiotics with broad-spectrum coverage of Gram-positive, Gram-negative and anaerobic pathogens similar to imipenem and, especially, meropenem. ...When P. aeruginosa or multidrug-resistant Gram-positive path …
Doripenem is a new member of the carbapenem class of beta-lactam antibiotics with broad-spectrum coverage of Gram-positive, Gram-nega …
Doripenem in the Treatment of Patients with Nosocomial Pneumonia: A Meta-Analysis.
Huang C, Chen I, Yang Y. Huang C, et al. J Clin Med. 2022 Jul 11;11(14):4014. doi: 10.3390/jcm11144014. J Clin Med. 2022. PMID: 35887777 Free PMC article. Review.
INTRODUCTION: Clinically, doripenem therapy for nosocomial pneumonia remains a serious concern. The purpose of this meta-analysis was to explore the efficacy and the safety of doripenem therapy for nosocomial pneumonia in comparison with other antimicrobial agents. …
INTRODUCTION: Clinically, doripenem therapy for nosocomial pneumonia remains a serious concern. The purpose of this meta-analysis was …
Doripenem.
[No authors listed] [No authors listed] 2017 Jan 17. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2017 Jan 17. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643441 Free Books & Documents. Review.
Doripenem is a broad spectrum carbapenem antibiotic used primarily for the treatment of aerobic gram-negative bacterial infections. Doripenem, like other carbapenems, is associated with transient and asymptomatic elevations in serum enzymes. ...
Doripenem is a broad spectrum carbapenem antibiotic used primarily for the treatment of aerobic gram-negative bacterial infections. …
Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program.
Wagenlehner FM, Sobel JD, Newell P, Armstrong J, Huang X, Stone GG, Yates K, Gasink LB. Wagenlehner FM, et al. Clin Infect Dis. 2016 Sep 15;63(6):754-762. doi: 10.1093/cid/ciw378. Epub 2016 Jun 16. Clin Infect Dis. 2016. PMID: 27313268 Free PMC article. Clinical Trial.
The phase 3 RECAPTURE program compared the efficacy and safety of ceftazidime-avibactam and doripenem in patients with complicated urinary tract infection (cUTI), including acute pyelonephritis. ...RESULTS: Of 1033 randomized patients, 393 and 417 treated with ceftazidime- …
The phase 3 RECAPTURE program compared the efficacy and safety of ceftazidime-avibactam and doripenem in patients with complicated ur …
Comparative review of the carbapenems.
Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstein E, Hoban DJ, Noreddin AM, Karlowsky JA. Zhanel GG, et al. Drugs. 2007;67(7):1027-52. doi: 10.2165/00003495-200767070-00006. Drugs. 2007. PMID: 17488146 Review.
Later additions to the class such as meropenem, ertapenem and doripenem demonstrated increased stability to DHP-1 and are administered without a DHP-1 inhibitor. ...Clinical trials are required to establish the efficacy and safety of doripenem in moderate to severe …
Later additions to the class such as meropenem, ertapenem and doripenem demonstrated increased stability to DHP-1 and are administere …
Doripenem: S 4661.
[No authors listed] [No authors listed] Drugs R D. 2003;4(6):363-5. doi: 10.2165/00126839-200304060-00006. Drugs R D. 2003. PMID: 14584966 Review.
Doripenem [S 4661] is a new parenteral carbapenem antibacterial undergoing clinical trials in Japan and North America. ...Shionogi will manufacture doripenem for worldwide distribution. Doripenem is currently undergoing phase III trials in Japan for pneumonia …
Doripenem [S 4661] is a new parenteral carbapenem antibacterial undergoing clinical trials in Japan and North America. ...Shionogi wi …
Doripenem: a review of its use in the treatment of bacterial infections.
Keam SJ. Keam SJ. Drugs. 2008;68(14):2021-57. doi: 10.2165/00003495-200868140-00007. Drugs. 2008. PMID: 18778123 Review.
Doripenem, a parenteral, broad-spectrum antibacterial agent of the carbapenem family, is indicated as empirical therapy in serious bacterial infections in adults. ...Thus, doripenem is a valuable addition to the options available for the empirical treatment of serio …
Doripenem, a parenteral, broad-spectrum antibacterial agent of the carbapenem family, is indicated as empirical therapy in serious ba …
Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
Matthews SJ, Lancaster JW. Matthews SJ, et al. Clin Ther. 2009 Jan;31(1):42-63. doi: 10.1016/j.clinthera.2009.01.013. Clin Ther. 2009. PMID: 19243706 Review.
Search terms included, but were not limited to, doripenem, S-4661, spectrum of activity, resistance, pharmacology, pharmacokinetics, pharmacodynamics, adverse events, and therapeutic use. ...A large Phase III study in the treatment of cIAIs found doripenem noninferi …
Search terms included, but were not limited to, doripenem, S-4661, spectrum of activity, resistance, pharmacology, pharmacokinetics, …
853 results